Why Choose Between Wegovy and Mounjaro at EverydayMeds?
Understanding Your Options When Switching From Wegovy to Mounjaro
The decision between Wegovy (semaglutide) and Mounjaro (tirzepatide) represents a choice between two distinct but effective approaches to prescription weight management. Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro takes a dual-hormone approach, targeting both GLP-1 and GIP receptors simultaneously, which may offer different benefits for some individuals considering switching from Wegovy to Mounjaro.
Both treatments require careful consideration of your individual health profile, previous treatment responses, and lifestyle factors. EverydayMeds provides access to both options through our qualified prescribers, ensuring you receive appropriate clinical assessment whether you're exploring switching from Wegovy to Mounjaro or starting weight management treatment for the first time. The choice between these prescription-only medicines should always be made with professional medical guidance rather than patient preference alone.
Pricing Comparison for Wegovy vs Mounjaro Treatment Options
EverydayMeds offers transparent pricing for both treatment pathways, with Wegovy starting at £79.99 for the 0.25mg starter dose using code FIRST40 for new customers. Our comprehensive bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99, providing your first two months of treatment in one convenient order. Returning customers benefit from code DOSE25 applied at checkout, whilst the maintenance dose of 2.4mg costs £209.99 per pen. The Ultimate Stability Trio provides three months of maintenance supply at 2.4mg for £649.99, offering long-term treatment security.
When considering switching from Wegovy to Mounjaro, pricing structures differ due to distinct dosing requirements and titration schedules. Both treatments require gradual dose escalation over several months to minimise potential side effects and optimise therapeutic response. EverydayMeds maintains competitive pricing across both treatment options, with bundle discounts available for customers planning extended treatment courses. Your total treatment cost depends on individual dose escalation timelines and maintenance requirements determined by your prescriber.
Clinical Evidence Supporting Switching From Wegovy to Mounjaro Decisions
Wegovy's efficacy stems from robust clinical evidence including the landmark STEP trials programme. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo, as reported by Wilding et al., NEJM, 2021. The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events with semaglutide treatment.
Mounjaro's clinical profile emerges from separate trial programmes with different populations and endpoints, making direct comparison inappropriate. Both treatments have undergone rigorous MHRA evaluation and received UK marketing authorisation for weight management in appropriate patient populations. Your prescriber can review individual trial data relevance when discussing potential switching from Wegovy to Mounjaro based on your specific health circumstances.
How Wegovy Works for Weight Management When Switching From Wegovy to Mounjaro
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone naturally produced in your intestine when you eat. This medication works on specific brain centres that control appetite, helping reduce food cravings and promoting feelings of fullness after smaller meals. The weekly injection provides consistent medication levels, supporting sustained appetite regulation throughout your treatment course. Wegovy may slow gastric emptying, contributing to prolonged satiety and reduced overall caloric intake when combined with dietary modifications. Unlike some weight management approaches, Wegovy's mechanism addresses biological appetite regulation rather than simply providing temporary appetite suppression, supporting more sustainable weight management outcomes.
Streamlined Ordering Process for Switching From Wegovy to Mounjaro Consultations
EverydayMeds simplifies access to both Wegovy and Mounjaro through our comprehensive online clinical assessment, completed in approximately three minutes. Our qualified prescribers review each application within three working days (express 24-hour service available), ensuring appropriate treatment selection whether you're switching from Wegovy to Mounjaro or starting initial therapy. Once approved, medications ship via next-day cold-chain delivery, maintaining temperature integrity throughout transport. Our GPhC-registered pharmacy (#9012878) ensures all medications meet pharmaceutical standards from storage through delivery. The assessment covers medical history, current medications, weight management goals, and previous treatment responses, providing prescribers with comprehensive information for treatment decisions.
Storage and Practical Considerations When Switching From Wegovy to Mounjaro
Wegovy offers storage advantages with six weeks of room temperature stability below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use, making travel planning important for extended trips. The FlexTouch pen delivery system provides consistent dosing with simple operation, whilst the mandatory dose escalation schedule requires careful planning for prescription refills. Wegovy's five-dose escalation (0.25mg to 2.4mg over 16 weeks) differs from Mounjaro's six-dose pathway, affecting long-term prescription planning. Understanding these practical differences helps ensure treatment continuity whether maintaining Wegovy therapy or switching from Wegovy to Mounjaro under prescriber guidance.
Treatment Transition Strategies for Switching From Wegovy to Mounjaro
Patients considering switching from Wegovy to Mounjaro require careful transition planning with prescriber oversight. The different receptor mechanisms (GLP-1 only versus dual GIP/GLP-1) mean switching isn't simply a direct dose conversion but requires individual assessment of previous treatment response, tolerability, and therapeutic goals. Timing considerations include washout periods, dose titration requirements, and monitoring for different side effect profiles between treatments.
EverydayMeds prescribers evaluate multiple factors when supporting treatment transitions, including previous dose tolerance, weight management progress, side effect experiences, and lifestyle compatibility. Some patients benefit from switching from Wegovy to Mounjaro due to different efficacy profiles or tolerability patterns, whilst others achieve optimal results maintaining Wegovy therapy. The decision requires personalised medical assessment rather than general treatment preferences, ensuring safe and effective transition when appropriate.
Expert Guidance for Switching From Wegovy to Mounjaro at EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds, providing you with comprehensive treatment options backed by expert prescriber support. New customers receive £40 off their first order with code FIRST40, whilst returning customers benefit from code DOSE25 applied at checkout. Our clinical team reviews each case individually, ensuring appropriate treatment selection whether you're exploring switching from Wegovy to Mounjaro or continuing current therapy. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which prescription-only medicine best supports your weight management goals. With next-day delivery and comprehensive ongoing support, EverydayMeds makes professional weight management treatment accessible and convenient throughout your journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
